Ibrance Users greater than 24 months
How many of us have used Ibrance (plus an antiestrogen) greater than 24 months - even those who have moved on to next line of treatment.
Apparently, the median PFS on this combo is now 27.6 months. For bone mets only the median PFS at 36.2 months. Data is from the Paloma 2 trial.